Medtronic Initiates Global Study of Minimally Invasive Technology to Aid Lung Cancer Diagnosis

By: via Benzinga
Medtronic's (NYSE: MDT) Minimally Invasive Therapies Group recently launched a 2,500-patient, international study to assess real-world ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.